Moxetumomab pasudotox and Peginterferon beta-1a
Determining the interaction of Moxetumomab pasudotox and Peginterferon beta-1a and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: peginterferon beta-1a
Brand name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon Beta-1a
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Peginterferon beta-1a Subcutaneous
- Moxetumomab pasudotox-PegIntron
- Moxetumomab pasudotox-Pegloticase
- Moxetumomab pasudotox-Pegloticase Intravenous
- Moxetumomab pasudotox-Pegvaliase
- Moxetumomab pasudotox-Pegvaliase-pqpz
- Peginterferon beta-1a-Moxetumomab Pasudotox-tdfk
- Peginterferon beta-1a-Moxetumomab pasudotox-tdfk Intravenous
- Peginterferon beta-1a-Moxifloxacin
- Peginterferon beta-1a-Moxifloxacin (Systemic)
- Peginterferon beta-1a-Moxifloxacin Hydrochloride
- Peginterferon beta-1a-Moxifloxacin Injection